Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27859489)

Published in Hepatology on November 18, 2016

Authors

Constantine J Karvellas1, Jaime L Speiser2, Mélanie Tremblay3, William M Lee4, Christopher F Rose3, US Acute Liver Failure Study Group

Author Affiliations

1: Divisions of Hepatology and Critical Care Medicine, University of Alberta, Edmonton, AB, Canada.
2: Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC.
3: Hepato-neuro Laboratory, CRCHUM, Université de Montréal, Montréal, Canada.
4: Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.

Articles cited by this

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 70.41

A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52

Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology (2005) 10.66

Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43

Reducing paracetamol overdoses. BMJ (1996) 5.34

Acute liver failure: redefining the syndromes. Lancet (1993) 4.99

Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet (2002) 3.73

Acute liver failure. Lancet (2010) 3.39

Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta (2005) 2.40

Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology (2002) 2.33

Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology (2014) 1.89

Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl (2000) 1.88

Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem (2003) 1.85

Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis (1978) 1.47

MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology (2007) 1.37

The cellular fatty acid binding proteins: aspects of structure, regulation, and function. Int Rev Cytol (1988) 1.24

Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury. Am J Pathol (2009) 1.12

Classification of acute liver failure. Lancet (1993) 1.03

Fatty acid-binding protein and its relation to fatty acid oxidation. Mol Cell Biochem (1993) 1.01

Ability of King's College Criteria and Model for End-Stage Liver Disease Scores to Predict Mortality of Patients With Acute Liver Failure: A Meta-analysis. Clin Gastroenterol Hepatol (2015) 1.01

Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study. Ann Intern Med (2016) 0.97

Liver fatty acid-binding protein as a sensitive serum marker of acute hepatocellular damage in liver transplant recipients. Clin Chem (2002) 0.95

Randomized controlled trial analyzing the effect of 15 or 30 min intermittent Pringle maneuver on hepatocellular damage during liver surgery. J Hepatol (2010) 0.92

The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology (1993) 0.91

Liver fatty acid-binding protein is a diagnostic marker to detect liver injury due to chronic hepatitis C infection. Arch Med Res (2013) 0.86

Mitosis in hepatocytes is generally associated with elevated levels of the target polypeptide of a liver carcinogen. Differentiation (1985) 0.86

Enhanced expression of cytosolic fatty acid binding protein and fatty acid uptake during liver regeneration in rats. Mol Cell Biochem (2004) 0.85

Acinar heterogeneity of fatty acid binding protein expression in the livers of male, female and clofibrate-treated rats. Hepatology (1989) 0.84

Comparison of the missing-indicator method and conditional logistic regression in 1:m matched case-control studies with missing exposure values. Am J Epidemiol (2004) 0.83

Medical and psychiatric outcomes for patients transplanted for acetaminophen-induced acute liver failure: a case-control study. Liver Int (2010) 0.83

Detection of brain injury by fatty acid-binding proteins. Clin Chem Lab Med (2005) 0.82

Predicting outcome on admission and post-admission for acetaminophen-induced acute liver failure using classification and regression tree models. PLoS One (2015) 0.79

Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury. Liver Int (2016) 0.79

Development of a Model to Predict Transplant-free Survival of Patients With Acute Liver Failure. Clin Gastroenterol Hepatol (2016) 0.78

Liver fatty acid-binding protein in two cases of human lipid storage. Mol Cell Biochem (1991) 0.77

Articles by these authors

Therapeutic hypothermia in acute liver failure: a multicenter retrospective cohort analysis. Liver Transpl (2015) 2.44

Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. Hepatology (2006) 1.83

Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatol (2014) 1.45

Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States. J Viral Hepat (2005) 1.19

Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure. Liver Transpl (2008) 1.09

Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study. Liver Int (2014) 0.89

Predicting outcome on admission and post-admission for acetaminophen-induced acute liver failure using classification and regression tree models. PLoS One (2015) 0.79

Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States. Liver Transpl (2016) 0.77

Detection of Ophthalmic Acid in Serum from Acetaminophen-Induced Acute Liver Failure Patients Is More Frequent in Non-Survivors. PLoS One (2015) 0.76

Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure. Liver Int (2014) 0.76

The role of hepatitis E virus infection in adult Americans with acute liver failure. Hepatology (2016) 0.75

Serum protein S-100b in acute liver failure: Results of the US Acute Liver Failure Study group. Liver Transpl (2003) 0.75

Critical Care management of the cirrhotic patient awaiting liver transplant in the Intensive Care Unit. Liver Transpl (2017) 0.75

HBV-Associated Acute Liver Failure After Immunosuppression and Risk of Death. Clin Gastroenterol Hepatol (2016) 0.75

In reply: Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure. Hepatology (2017) 0.75

The association between FABP7 serum levels with survival and neurological complications in acetaminophen-induced acute liver failure: a nested case-control study. Ann Intensive Care (2017) 0.75

Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology (2017) 0.75

Acute liver injury and acute liver failure from mushroom poisoning in North America. Liver Int (2016) 0.75

Liver transplant in acute-on-chronic liver failure: Evaluating the impact of organ dysfunction. Liver Int (2017) 0.75

Acetaminophen-induced Acute Liver Failure is More Common and More Severe in Women. Clin Gastroenterol Hepatol (2017) 0.75